Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Crystallization . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101921211A details a novel crystallization method for oxytetracycline. This process enhances purity and yield while simplifying supply chain logistics for veterinary manufacturers.
Patent CN103923024B details water based recrystallization improving purity and yield reducing solvent toxicity for scalable acipimox manufacturing supply chains
Patent CN1134447C reveals a novel purification method for cefixime intermediates using tert-octylamine salts, offering high purity and scalable manufacturing solutions.
Advanced purification technology for SYR-322 intermediates ensuring high purity and supply chain stability for global pharmaceutical manufacturing partners.
Patent CN102260244B details a stable rabeprazole sodium synthesis with 99.9% purity. Offers superior moisture stability and cost-effective manufacturing for global supply chains.
Patent CN112457307B details a biocatalytic extraction process achieving 100% optical purity. This method offers significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing.
Patent CN111763150B reveals a novel L-glutamic acid resolution method for high-purity sertraline, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN102249974A details a high-purity crystallization method for Levo-Oxiracetam, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN105541953B details a recrystallization method achieving high purity without column chromatography, offering significant cost reduction in API manufacturing and supply chain reliability.
Patent CN106478747B reveals high-yield sulfonated sugar synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Advanced isothermal purification method for Esomeprazole Sodium achieving >99.5% purity. Reduces solvent residue and ensures supply chain stability for global API manufacturers.
Advanced synthesis of Montelukast Sodium via CN111892535B. Achieves >99.8% purity and >93.5% yield without expensive ionic liquids, offering significant cost reduction.
Patent CN105646446B enables ethanol-based purification of Alogliptin intermediates reducing hazardous waste and improving supply chain reliability for global manufacturers.
Discover the patented protic solvent method for producing high-purity ketimines. A cost-effective, scalable solution for pharmaceutical intermediate manufacturing.
Patent CN116874446B details a novel MOPSO-Na synthesis route offering high purity and recyclable solvents, ensuring cost reduction in pharmaceutical intermediate manufacturing.
Patent CN114621128A reveals a novel TBS-protection strategy for (S)-oxiracetam, eliminating column chromatography to ensure >99.9% purity and significant cost reduction.
Advanced melt crystallization patent CN107266294A ensures 99.5% purity. Reduces energy consumption and improves supply chain reliability for global buyers.
Patent CN107674072B reveals a scalable resolution method for dihydropyrimidine intermediates using L-tartaric acid, offering superior optical purity and cost-effective manufacturing for pharmaceutical supply chains.
Patent CN112851560A reveals a cost-effective racemization method for cis-D-hydroxyproline, offering high purity >99.5% and scalable production for pharma intermediates.
Patent CN108929335B details a resin-based purification method for Tacrolimus, offering high purity, reduced solvent use, and scalable manufacturing for global supply chains.